2021. Safety and effectiveness of new embolization microspheres SCBRM for intermediate-stage hepatocellular carcinoma: A feasibility study. Biomolecules and Biomedicine. 21, 3 (Jun. 2021), 339–345. DOI:https://doi.org/10.17305/bjbms.2020.4770.